Correction to: Secukinumab: A Review in Moderate to Severe Pediatric Plaque Psoriasis

Infliximab Benefits Long-Lasting in Plaque Psoriasis Phase III Trial

Skin & Allergy News ◽

10.1016/s0037-6337(05)70457-5 ◽

2005 ◽

Vol 36 (8) ◽

pp. 2

Author(s):

NANCY WALSH

Keyword(s):

Plaque Psoriasis ◽

Phase Iii ◽

Phase Iii Trial

Download Full-text

Severe Chronic Plaque Psoriasis Increases Arterial Stiffness Risk

Skin & Allergy News ◽

10.1016/s0037-6337(08)70558-8 ◽

2008 ◽

Vol 39 (8) ◽

pp. 30

Author(s):

BRUCE JANCIN

Keyword(s):

Arterial Stiffness ◽

Plaque Psoriasis ◽

Chronic Plaque Psoriasis

Download Full-text

FDA Approves New Vitamin D Topical for Plaque Psoriasis

Skin & Allergy News ◽

10.1016/s0037-6337(09)70060-9 ◽

2009 ◽

Vol 40 (3) ◽

pp. 14

Author(s):

DAMIAN MCNAMARA

Keyword(s):

Vitamin D ◽

Plaque Psoriasis

Download Full-text

Biologics Compared For Plaque Psoriasis

Skin & Allergy News ◽

10.1016/s0037-6337(07)70846-x ◽

2007 ◽

Vol 38 (11) ◽

pp. 9

Author(s):

BRUCE JANCIN

Keyword(s):

Plaque Psoriasis

Download Full-text

First "Real-World" Insights on Apremilast Treatment for Patients with Plaque Psoriasis from the LAPIS-PSO Study: An Interim Analysis

SKIN The Journal of Cutaneous Medicine ◽

10.25251/skin.1.supp.14 ◽

2017 ◽

Vol 1 ◽

pp. s15 ◽

Cited By ~ 2

Author(s):

Kristian Reich ◽

Stefanie Bomas ◽

Bernhard Korge ◽

Maria Manasterski ◽

Uwe Schwitchtenberg ◽

...

Keyword(s):

Real World ◽

Plaque Psoriasis ◽

Interim Analysis

Abstract Not Available Disclosure: Study supported by Celgene.

Download Full-text

Bimekizumab provides rapid and sustained improvements in scalp and nail outcomes in patients with moderate to severe plaque psoriasis: 60 week results from a randomized, double blinded, Phase 2b extension study

SKIN The Journal of Cutaneous Medicine ◽

10.25251/skin.3.supp.34 ◽

2019 ◽

Vol 3 ◽

pp. S34

Author(s):

Andrew Blauvelt ◽

Kim A Papp ◽

Joseph F Merola ◽

Alice B Gottlieb ◽

Nancy Cross ◽

...

Keyword(s):

Plaque Psoriasis ◽

Extension Study ◽

Severe Plaque Psoriasis ◽

Double Blinded

Abstract not available.

Download Full-text

PPC 06 ( Tepilamide Fumarate), a novel fumaric acid ester, is efficacious in treating plaque psoriasis: Results from a phase 2b randomized controlled trial

SKIN The Journal of Cutaneous Medicine ◽

10.25251/skin.3.supp.33 ◽

2019 ◽

Vol 3 ◽

pp. S33

Author(s):

Mark Lebwohl ◽

Leon Kircik ◽

Kristian Reich ◽

Sugar Munjal ◽

Srinivas Shenoy ◽

...

Keyword(s):

Randomized Controlled Trial ◽

Fumaric Acid ◽

Plaque Psoriasis ◽

Acid Ester ◽

Controlled Trial ◽

Randomized Controlled ◽

Fumaric Acid Ester

Abstract not available.

Download Full-text

Efficacy of Halobetasol 0.01%/Tazarotene 0.045% (HP/TAZ) Fixed Combination in the Treatment of Moderate Plaque Psoriasis: Indirect Comparison Between Pooled Phase 3 Trials of HP/TAZ and Oral Treatment (Apremilast)

SKIN The Journal of Cutaneous Medicine ◽

10.25251/skin.3.supp.30 ◽

2019 ◽

Vol 3 ◽

pp. S30

Author(s):

Brad Glick ◽

Edward Lain ◽

Tina Lin ◽

Robert Israel

Keyword(s):

Plaque Psoriasis ◽

Fixed Combination ◽

Oral Treatment ◽

Indirect Comparison ◽

Phase 3

Abstract not available.

Download Full-text

Patient-reported outcomes in subjects with plaque psoriasis treated with tapinarof cream: Results from a phase 2b, randomized parallel-group study

SKIN The Journal of Cutaneous Medicine ◽

10.25251/skin.2.supp.86 ◽

2018 ◽

Vol 2 ◽

pp. S85

Author(s):

Neal Bhatia ◽

David Rubenstein ◽

Anna M Tallman ◽

James Lee

Keyword(s):

Plaque Psoriasis ◽

Patient Reported Outcomes ◽

Parallel Group Study ◽

Parallel Group ◽

Patient Reported

Download Full-text

Real World Patient Perceptions of the use of Calcipotriene Foam 0.005% in the Treatment of Plaque Psoriasis

SKIN The Journal of Cutaneous Medicine ◽

10.25251/skin.3.supp.19 ◽

2019 ◽

Vol 3 ◽

pp. S19

Author(s):

Francisco Kerdel ◽

Christina Don ◽

Renata Block ◽

Caitlin Lewis ◽

Rhonda Schreiber

Keyword(s):

Real World ◽

Plaque Psoriasis ◽

Patient Perceptions

Abstract not available.

Download Full-text